Record Issuance Meets a Market Structure Rewrite: The 2026 IPO and Liquidity Landscape

The United States is in the middle of its most intense equity issuance cycle since 2021, and the market plumbing beneath it is being rewired at the same time. SK hynix, the South Korean memory chipmaker and key Nvidia supplier, priced 177.9 million American Depositary Receipts at $149 apiece on July 9, raising $26.5 billion in the largest foreign-company listing in US history{{cite:00ad0270d4d3}}. The deal was more than seven times oversubscribed{{cite:00ad0270d4d3}} and the ADRs were set to begin trading on Nasdaq the morning of July 10 under the ticker SKHY{{cite:00ad0270d4d3}}.

That single deal is emblematic of a broader surge. Through July 2, 2026, US exchanges had hosted 194 IPOs raising a cumulative $155.8 billion, with SpaceX’s $86.2 billion listing alone accounting for more than half{{cite:f26d41afadea}}. Even excluding SpaceX, the remaining $69.9 billion of IPO volume was more than double the $31.6 billion printed over the same period in 2025{{cite:f26d41afadea}}. US ECM proceeds across all categories topped $120 billion year-to-date through June, the strongest first-half pace since 2021{{cite:834c5be662e5}}.

The Issuance Wave: Scale, Composition, and the Historical Anchor

The headline numbers are striking, but the question that matters for investors is whether record issuance drains liquidity from existing equities or signals a healthy market absorbing new supply. UBS frames the answer through a base-rate lens: IPO issuance is on track to reach $200–350 billion this year, with secondary offerings potentially exceeding $400 billion — both potential record highs in absolute dollars{{cite:7cef8190ece9}}. But measured against total US equity market capitalization of roughly $72 trillion, that issuance is only slightly above the long-term average as a percentage of the Russell 3000 free float{{cite:7cef8190ece9}}.

The critical distinction is gross versus net. US share buybacks totaled $1.2 trillion over the past 12 months, and UBS expects repurchases to remain near that level through year-end{{cite:7cef8190ece9}}. If the corporate sector buys back slightly more stock than it issues, net equity supply still shrinks — a fundamentally supportive condition for existing shareholders even amid a torrent of new listings.

Goldman Sachs Research reaches a similar conclusion from a different angle. Chief US equity strategist Ben Snider has noted that IPO activity is best understood as a coincident indicator rather than a leading one: issuance rises when markets are strong and falls when conditions weaken, but there is no consistent relationship between changes in IPO activity and forward market returns{{cite:d098e479add4}}{{cite:7cef8190ece9}}. Even the five largest US-domiciled IPOs since 1990 showed no discernible effect on broader equity performance in the surrounding weeks{{cite:7cef8190ece9}}.

What is actually being issued

The composition of the 2026 class reveals a market that is both thematically concentrated and broader than the 2021 SPAC cycle:

AI infrastructure is the dominant thematic lane. Cerebras Systems raised $5.55 billion on May 13 in the largest US tech IPO since Snowflake, pricing at $185 — well above its marketed range — and opening at $350, a roughly 90 percent first-day pop that pushed its market capitalization past $95 billion{{cite:31b8d81293e2}}. Fervo Energy raised $1.89 billion and Forgent Power $1.5 billion, reflecting a world structurally short on electricity for data centers{{cite:834c5be662e5}}. Roughly half of convertible issuance is AI-linked{{cite:834c5be662e5}}.

The pipeline for the second half is deep. Anthropic and OpenAI have both confidentially filed for IPOs{{cite:f26d41afadea}}. Kraken and Plaid, together targeting roughly $8 billion, sit in the Q2/Q3 pipeline{{cite:834c5be662e5}}. Google raised $50 billion in equity in roughly two days of market activity, demonstrating that even mega-cap primary issuance can be absorbed without disruption{{cite:f26d41afadea}}.

The Concentration Risk: What Would Have to Be True for the Optimistic Case to Fail

The balanced view requires identifying the conditions under which the issuance wave becomes a problem rather than a symptom. Three stand out.

AI sentiment shift. The 2026 IPO calendar is heavily concentrated in AI-infrastructure names. ArcStone notes that Cerebras, Fervo, and the broader AI-power nexus account for a disproportionate share of proceeds, and that concentration introduces fragility if AI sentiment shifts{{cite:834c5be662e5}}. Healthcare IPOs, which posted +43.6 percent average returns in Q1, rotated to -6.2 percent year-to-date in Q2 as capital migrated toward AI{{cite:834c5be662e5}} — a reminder that sector rotation within the IPO market can be swift.

SpaceX lockup risk. ION Analytics reports that several SpaceX insider lockups are set to expire around the company’s first listed earnings report in late July or early August{{cite:f26d41afadea}}. One banker cautioned: “If SpaceX starts to trade down that could close the door for other AI issuers”{{cite:f26d41afadea}}. The SpaceX IPO was fueled partly by retail FOMO and a narrative around orbital data centers and xAI compute monetization that attracted investors willing to set aside traditional fundamental analysis{{cite:f26d41afadea}}. Whether that narrative survives contact with reported financials is an open question.

LLM provider skepticism. Both Anthropic and OpenAI are seeking to list at a time when skepticism toward large language model providers is growing, even from voices previously counted among the technology’s strongest supporters{{cite:f26d41afadea}}. One US investor warned that both companies “don’t have the idiosyncratic features that the SpaceX setup had” and expressed concern about both listing in close succession{{cite:f26d41afadea}}.

For the optimistic case to hold, three things need to remain true: institutional and retail capital continues to fund the AI buildout story, SpaceX’s first earnings do not trigger a broad de-rating of the 2026 IPO class, and the macro backdrop — funds at 3.50–3.75 percent, VIX near 16.76, 10-year yield at 4.59 percent{{cite:834c5be662e5}} — does not deteriorate sharply.

The Market Structure Rewrite: Two Decades of Plumbing Under Review

While issuance dominates the headlines, the SEC is simultaneously proposing the most significant changes to US equity market structure in two decades. On June 11, 2026, the Commission proposed amendments to Regulation NMS that would rescind Rule 611 — the Order Protection Rule, commonly known as the trade-through rule — along with Rule 610(e), the prohibition on locked and crossed markets{{cite:e605121fb4a2}}. Comments are due by August 17, 2026{{cite:e605121fb4a2}}.

The Order Protection Rule rescission

Rule 611 has required every trading center — exchanges, ATSs, and internalizing broker-dealers — to establish procedures preventing trade-throughs of protected quotations in NMS stocks since Regulation NMS was adopted in 2005{{cite:e605121fb4a2}}. The SEC’s stated rationale for rescission is that today’s highly automated, interconnected markets make mandatory order protection obsolete: routing technology is sophisticated, and broker-dealer best execution obligations provide a sufficient backstop{{cite:e605121fb4a2}}.

The SEC also argues Rule 611 has increased costs and complexity, contributing to exchange proliferation and the growth of order types designed around compliance rather than efficiency{{cite:e605121fb4a2}}. Under the proposal, any new exchange could no longer effectively force market participants to connect to it simply by displaying a protected quotation{{cite:e605121fb4a2}}.

Critics raise substantive concerns. Without the regulatory floor, trades may lawfully occur at prices that would previously have constituted a trade-through, placing heightened pressure on broker-dealer best execution analyses{{cite:e605121fb4a2}}. Locked and crossed markets could be displayed to investors making routing decisions, potentially causing confusion{{cite:e605121fb4a2}}. And on June 12, the SEC separately proposed a 5:1 cap on each exchange’s quote-to-trade revenue ratio in the CT Plan’s consolidated market data allocation{{cite:e605121fb4a2}} — a change that, combined with the loss of protected-quotation status, could create economic pressure on low-volume exchanges and reduce incentives for displayed liquidity.

The proposal also explicitly cites the emergence of tokenized NMS stocks and on-chain trading venues as a reason to reassess Rule 611, but does not explain how tokenized instruments would integrate with the existing equity market structure{{cite:e605121fb4a2}}. This leaves an open question about whether quotations and trades from tokenized venues would be reflected in consolidated market data or considered in best execution analyses.

Overnight price bands and 23/5 trading

In parallel, US exchanges are preparing for near-continuous overnight trading. The SEC has approved applications by 24X National Exchange, NYSE Arca, and Nasdaq to conduct trading on a 23/5 basis, with processors expected to commence overnight operations on December 6, 2026{{cite:e2ae96e6f0da}}.

On May 27, 2026, the exchanges filed the Twenty-Seventh Amendment to the Limit Up-Limit Down Plan, proposing temporary price band protections for the overnight session{{cite:e2ae96e6f0da}}. The framework sets Overnight Protected Hours as 9:00 PM to 4:00 AM Eastern Time, Sunday through Thursday{{cite:e2ae96e6f0da}}. Price bands would be calculated using two reference prices — the official closing price and a consolidated last sale as of 7:45 PM ET — with a 20 percent parameter above and below the wider of the two references{{cite:e2ae96e6f0da}}. This dual-reference approach is designed to account for post-market price movements that could make a single closing-price anchor stale by the time overnight trading begins{{cite:e2ae96e6f0da}}.

The participants estimate that the bands would affect an average of zero S&P 500 stocks, 0.6 ETPs, and 0.4 non-S&P 500 stocks per day — less than 0.1 percent of total overnight volume{{cite:e2ae96e6f0da}}. No automatic trading pauses are proposed for the overnight session; instead, primary listing exchanges retain discretion to declare regulatory halts that would remain in place for the rest of the overnight session{{cite:e2ae96e6f0da}}. A Phase 2 revision with sliding bands and potentially tighter parameters is expected in 2027{{cite:e2ae96e6f0da}}.

The 4:00 AM termination was chosen specifically to preserve unconstrained price discovery during pre-market hours, when companies release earnings and material disclosures{{cite:e2ae96e6f0da}}. This means that for newly listed stocks — which often see their most volatile price action in the first days after IPO — the overnight guardrails will apply only during the deepest liquidity trough, not during the pre-market window when most earnings-driven repricing occurs.

European Listings: The Counterfactual

The contrast with Europe is instructive. While the US IPO Health Index sits near post-2021 highs, the EMEA equivalent remains close to its post-2021 nadir{{cite:f26d41afadea}}. The most high-profile European IPO expected before the summer break — Franco-German tank maker KNDS — was postponed after family shareholders sought a valuation of at least EUR 12.5 billion while investors demanded a substantial discount against falling defence sector peers{{cite:f26d41afadea}}.

European IPOs suffer from a structurally smaller investor base — predominantly mutual funds and hedge funds with pockets of domestic demand — and investors who feel no obligation to buy deals and routinely demand at least a 30 percent discount to peers{{cite:f26d41afadea}}. As one banker close to the KNDS deal noted, European listing reforms have sped up preparation but the market still needs deeper pension fund and retail participation{{cite:f26d41afadea}}. The US, by contrast, can mobilize legions of retail investors and institutional money to create enough demand to push deals across the line, aided by accelerated index inclusion that forces passive buying{{cite:f26d41afadea}}.

SPACs: A Bifurcation, Not a Revival

SPAC issuance has surged roughly fourfold versus the same period in 2025, with approximately 80 SPAC IPOs raising about $14 billion through April{{cite:834c5be662e5}}. But this cycle is concentrated among institutional-grade sponsors with performance-based promotes and committed PIPE financing, aided by the SEC’s 2024 disclosure reforms{{cite:834c5be662e5}}. The pressure on legacy vehicles is acute: of 352 active SPACs with 111 pending de-SPAC transactions, only 11 have closed year-to-date, with redemption rates above 95 percent{{cite:834c5be662e5}}. ArcStone estimates 25–35 percent of active vehicles will extend or liquidate{{cite:834c5be662e5}}.

What to Watch Next

• SK hynix first-day performance (July 10). The $26.5 billion deal was more than 7x oversubscribed{{cite:00ad0270d4d3}}. First-day price action will be a real-time test of whether the market can absorb a deal of this size without indigestion, and whether the AI-memory thematic has room beyond Nvidia itself.

• SpaceX first earnings report (late July / early August). Concurrent insider lockup expirations{{cite:f26d41afadea}} mean that the first public financial disclosures will coincide with the first opportunity for insiders to sell. This is the single highest-impact event for the 2026 IPO class sentiment.

• Anthropic IPO filing progression. Anthropic has confidentially filed{{cite:f26d41afadea}} and is widely expected to price before OpenAI. The reception of the first pure-play LLM provider IPO will set the template for how the market values frontier AI models.

• SEC Order Protection Rule comment deadline (August 17). The comment period will surface the positions of exchanges, broker-dealers, and institutional investors on whether rescission reduces fragmentation or creates new execution risk{{cite:e605121fb4a2}}.

• Overnight trading launch (December 6). Processor readiness and the Phase 1 price band calibration will determine whether 23/5 trading attracts meaningful volume or remains a thin, guardrailed session{{cite:e2ae96e6f0da}}.

• Buyback pace versus issuance. If corporate repurchases slow — as some analysts have noted amid the AI capex arms race{{cite:72ddb5803bce}} — the net supply equation could shift from supportive to neutral or even dilutive, changing the base-rate calculus that UBS and Goldman currently favor.

The 2026 issuance wave is, by most historical analogs, a sign of market health rather than a warning signal. But it is arriving at a moment when the regulatory architecture underneath — the trade-through rule, the tick-size regime, the scope of overnight protections — is being renegotiated simultaneously. The companies going public this year will inherit a market structure that may look materially different by the time their lockups expire.